Literature DB >> 25269997

Persistent pure red cell aplasia in dicygotic twins with persistent congenital parvovirus B19 infection-remission following high dose intravenous immunoglobulin.

Alice Lejeune1, Malte Cremer, Horst von Bernuth, Anke Edelmann, Susanne Modrow, Christoph Bührer.   

Abstract

UNLABELLED: We report the course of dicygotic twins born preterm after 29 (4)/7 weeks of gestation due to congenital Parvovirus B19 infection causing fetal hydrops with severe anemia in one infant in whom intrauterine transfusion was impossible to perform and high levels of viremia in both infants. After being discharged, they were readmitted at 3 months of age with critical aplastic crisis. Therapy with intravenous immunoglobulin infusion resulted in decreasing viremia followed by stable hemoglobin levels in both infants.
CONCLUSION: Intravenous immunoglobulin treatment of congenital pure red cell aplasia due to Parvovirus B19 infection in preterm infants seems to be effective to introduce viral remission and to normalize erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269997     DOI: 10.1007/s00431-014-2420-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation.

Authors:  Frank Blaeser; Michael Kelly; Karen Siegrist; Gregory A Storch; Richard S Buller; Jessica Whitlock; Nga Truong; Talal A Chatila
Journal:  Clin Immunol       Date:  2005-10-05       Impact factor: 3.969

2.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

Review 3.  Parvovirus B19 in pregnancy.

Authors:  Zivanit Ergaz; Asher Ornoy
Journal:  Reprod Toxicol       Date:  2006-05       Impact factor: 3.143

Review 4.  Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.

Authors:  Yoann Crabol; Benjamin Terrier; Flore Rozenberg; Vincent Pestre; Christophe Legendre; Olivier Hermine; Catherine Montagnier-Petrissans; Loïc Guillevin; Luc Mouthon
Journal:  Clin Infect Dis       Date:  2012-12-12       Impact factor: 9.079

Review 5.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

6.  Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.

Authors:  Betul Tavil; Ozden Sanal; Tuba Turul; Leman Yel; Aytemiz Gurgey; Fatma Gumruk
Journal:  Pediatr Hematol Oncol       Date:  2009-03       Impact factor: 1.969

7.  Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.

Authors:  Martin Enders; Andrea Weidner; Iris Zoellner; Karen Searle; Gisela Enders
Journal:  Prenat Diagn       Date:  2004-07       Impact factor: 3.050

Review 8.  Parvovirus B19 infection and hematopoiesis.

Authors:  K E Brown; N S Young
Journal:  Blood Rev       Date:  1995-09       Impact factor: 8.250

Review 9.  Parvovirus B19 and the pathogenesis of anaemia.

Authors:  Hiroshi Chisaka; Eiji Morita; Nobuo Yaegashi; Kazuo Sugamura
Journal:  Rev Med Virol       Date:  2003 Nov-Dec       Impact factor: 6.989

10.  Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Authors:  Lutz Liefeldt; Annelie Plentz; Boris Klempa; Olivia Kershaw; Anne-Sophie Endres; Ulla Raab; Hans-H Neumayer; Helga Meisel; Susanne Modrow
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

  10 in total
  2 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Congenital Parvovirus B19 Infection: Persistent Viremia and Red Blood Cell Aplasia.

Authors:  Sruti S Nadimpalli; Russell S Miller; Vasudeva M Kamath; Christiana R Farkouh; Chia-Ling Nhan-Chang; Jennifer A Rathe; Amélie Collins; Jennifer M Duchon; Natalie Neu; Lynn L Simpson; Adam J Ratner
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.